Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.23
Delayed Data
As of 3:59pm ET
 -0.0049 / -2.09%
Today’s Change
0.21
Today|||52-Week Range
0.40
-8.00%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.45, with a high estimate of 1.45 and a low estimate of 1.45. The median estimate represents a +530.43% increase from the last price of 0.23.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Hemispherx Biopharma Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -10.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 0.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account